Last updated on November 2019

Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease


Brief description of study

The primary objective of this study is to evaluate whether selonsertib (SEL) can slow the decline in kidney function, reduce the risk of kidney failure, or reduce the risk of death due to kidney disease in participants with diabetic kidney disease (DKD).

Clinical Study Identifier: NCT04026165

Find a site near you

Start Over

Meridien Research

Bradenton, FL United States
  Connect »